Emgality and Nitroglycerin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Emgality (galcanezumab-gnlm) and Nitroglycerin (nitroglycerin). Common drug interactions include ear disorder among females and migraine among males.

The phase IV clinical study analyzes what interactions people have when they take Emgality and Nitroglycerin. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Emgality?

Emgality has active ingredients of galcanezumab-gnlm. eHealthMe is studying from 24,702 Emgality users. Check the latest studies of Emgality.

What is Nitroglycerin?

Nitroglycerin has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 52,884 Nitroglycerin users. Check the latest studies of Nitroglycerin.

On Aug, 09, 2026

38 people who take Emgality and Nitroglycerin together, and have interactions are studied.

Emgality and Nitroglycerin drug interactions.

What are the common drug interactions of Emgality and Nitroglycerin, by gender? *:

female:

Ear disorder
Exostosis (formation of new bone on the surface of a bone)
Gait disturbance
Gastrointestinal disorder (functional problems of gastrointestinal tract)
General physical health deterioration (weak health status)
Hyperhidrosis (abnormally increased sweating)
Hypertension (high blood pressure)
Ill-defined disorder
Infusion site pruritus (severe itching at infusion site)
Localised infection (infection at the single location)

male:

Migraine (headache)
Cardiac disorder
Depression
Emotional distress
Osteonecrosis (death of bone)
Osteopenia (a condition where bone mineral density is lower than normal)
Pain
Arthralgia (joint pain)
Blood iron increased
Dizziness

What are the common drug interactions of Emgality and Nitroglycerin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Bone pain
Constipation
Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Localised infection (infection at the single location)
Nausea (feeling of having an urge to vomit)
Osteonecrosis (death of bone)
Pain in extremity
Thrombosis (formation of a blood clot inside a blood vessel)
Vomiting

50-59:

Migraine (headache)
Fatigue (feeling of tiredness)
Fall
Nausea (feeling of having an urge to vomit)
Pain
Pain in extremity
Back pain
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Dysarthria (speech disorder)
Hypoaesthesia (reduced sense of touch or sensation)

60+:

Corneal abrasion (loss of the surface of cornea)
Diarrhoea
Abdominal pain upper
Anxiety
Asthma
Cardiac disorder
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Constipation
Drug ineffective
Gait disturbance

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 11 people, 28.95%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 8 people, 21.05%
Depression: 5 people, 13.16%
Migraine (headache): 5 people, 13.16%
Restless Leg Syndrome (a powerful urge to move your legs): 4 people, 10.53%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 10.53%
High Blood Cholesterol: 4 people, 10.53%
High Blood Pressure: 4 people, 10.53%
Stress And Anxiety: 3 people, 7.89%
Cardiac Disorder: 3 people, 7.89%

* Approximation only. Some reports may have incomplete information.

Do you take Emgality and Nitroglycerin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously